|
ZNF583 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.43230000000528E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.295600E-01 |
| Normal-vs-Stage2 |
6.499700E-03 |
| Normal-vs-Stage3 |
6.54840000002821E-07 |
| Normal-vs-Stage4 |
1.89848137210902E-14 |
| Stage1-vs-Stage2 |
1.043890E-02 |
| Stage1-vs-Stage3 |
3.87420000003136E-06 |
| Stage1-vs-Stage4 |
1.6521228829447E-12 |
| Stage2-vs-Stage3 |
4.795800E-01 |
| Stage2-vs-Stage4 |
7.980800E-03 |
| Stage3-vs-Stage4 |
6.777500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.160350E-04 |
| Normal-vs-AfricanAmerican |
2.419900E-02 |
| Normal-vs-Asian |
7.050600E-01 |
| Caucasian-vs-AfricanAmerican |
9.318600E-01 |
| Caucasian-vs-Asian |
6.667000E-01 |
| AfricanAmerican-vs-Asian |
6.406800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.22579999999972E-05 |
| Normal-vs-Female |
2.764300E-02 |
| Male-vs-Female |
1.227360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.906600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.139190E-01 |
| Normal-vs-Age(61-80Yrs) |
6.3857999998973E-07 |
| Normal-vs-Age(81-100Yrs) |
1.477210E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.670000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.490600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.287980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.158300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.962260E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.454390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.301190E-01 |
| Normal-vs-Grade 2 |
7.747000E-01 |
| Normal-vs-Grade 3 |
1.49400000148958E-08 |
| Normal-vs-Grade 4 |
5.67323965583455E-14 |
| Grade 1-vs-Grade 2 |
2.668400E-01 |
| Grade 1-vs-Grade 3 |
1.878470E-03 |
| Grade 1-vs-Grade 4 |
6.36829999955957E-07 |
| Grade 2-vs-Grade 3 |
1.76650000183187E-08 |
| Grade 2-vs-Grade 4 |
1.66344715779587E-12 |
| Grade 3-vs-Grade 4 |
5.757300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.815400E-01 |
| Normal-vs-ccB subtype |
6.44080000444802E-08 |
| ccA subtype-vs-ccB subtype |
7.661499989986E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.384400E-04 |
| Normal-vs-N1 |
2.43879999528573E-08 |
| N0-vs-N1 |
1.539770E-02 |
|
|
